Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 42

Sort by

Sort Order Select

Journal Articles

Interrelation of 5q-Deletions and Mutations of TP53 in Patients with Myelodysplastic Syndromes and Complex Aberrations

Christina Ganster, Lea Naomi Eder, Katayoon Shirneshan, Katharina Rittscher, Paolo Mazzeo, Roxana Schaab, Ahmet H. Elmaagacli, Prof, MD PhD, Uwe Platzbecker, Bertram Glass, Ulrich Germing, Maria Kamper, Elzbieta Barbara Brzuszkiewicz, Detlef Haase, MD

Blood (2020) 136 (Supplement 1): 7.

https://doi.org/10.1182/blood-2020-142508

Published: 2020

Journal Articles

Mutation Profile of PPM1D and TP53 in Patients with Myelodysplastic Syndromes and Complex Chromosome Abnormalities

Blood (2019) 134 (Supplement_1): 2994.

https://doi.org/10.1182/blood-2019-126778

Published: 2019

Journal Articles

Long-Term Survival after Transplantation in Patients with Chronic Myeloid Leukemia from HLA-Compatible Unrelated Donors: May the Stem Cell Source Influence the Outcome?

Michael Koldehoff, Prof, MD PhD, Ahmet H. Elmaagacli, Prof, MD PhD, Hellmut Dietmar Ottinger, MD PhD, Ulrich Dührsen, Prof, MD PhD, Dietrich W. Beelen

Blood (2018) 132 (Supplement 1): 5775.

https://doi.org/10.1182/blood-2018-99-118615

Published: 2018

Journal Articles

Cytomegalovirus replication reduces the relapse incidence in patients with acute myeloid leukemia

Ahmet H. Elmaagacli, Michael Koldehoff

Blood (2016) 128 (3): 456–459.

https://doi.org/10.1182/blood-2016-04-713644

Published: 2016

Journal Articles

Higher Incidence of Secondary AML and Adverse Molecular Markers, Together with Lower CR and Higher AML Related Death Rates in Elderly Compared to Younger Patients: Results from 2435 Patients Included in the Two German AML Intergroup Studies

Blood (2015) 126 (23): 2517.

https://doi.org/10.1182/blood.V126.23.2517.2517

Published: 2015

Journal Articles

Role Of miRNA Expression As Novel Biomarker Of GvHD After Allogeneic Stem Cell Transplantation

Michael Koldehoff, MD, Nina K Steckel, MD, Christina Maniera, Ahmet H. Elmaagacli, MD, Dietrich W. Beelen, MD, PhD

Blood (2013) 122 (21): 4585.

https://doi.org/10.1182/blood.V122.21.4585.4585

Published: 2013

Journal Articles

Mer Receptor Tyrosine Kinase Is a Novel Therapeutic Target In Multiple Myeloma

Sandra Christoph, Silke Maag, Deborah DeRyckere, Douglas K. Graham, MD, PhD, Stephen V Frye, H. Shelton Earp, III, Jing Liu, Chao Yang, Weihe Zhang, Xiaodong Wang, Ahmet H. Elmaagacli, Dietrich Beelen, MD

Blood (2013) 122 (21): 1957.

https://doi.org/10.1182/blood.V122.21.1957.1957

Published: 2013

Journal Articles

Comparison Of Different Pretransplant Predictive Scores In Patients With Refractory Acute Myeloid Leukemia After Allogeneic Stem Cell Transplantation Including Highdose Melphalan: Results Of a Double-Center Observational Study

Nina Kristin Steckel, M.D., Markus Ditschkowski, MD, Christoph Groth, M.D., Gerda Silling, MD, U. Krug, MD, Rudolf Trenschel, MD, Hellmut Ottinger, MD, Wolfgang E Berdel, MD, Michael Koldehoff, MD, Ahmet H. Elmaagacli, Dietrich Beelen, MD, Matthias Stelljes, MD

Blood (2013) 122 (21): 4525.

https://doi.org/10.1182/blood.V122.21.4525.4525

Published: 2013

Journal Articles

Non Interventional Prospective Study On The Effect Of 48 Gene Variants On Different Endpoints After Allogeneic Stem Cell Transplantation For Patients With Acute Myeloid Leukemia

Michael Koldehoff, MD, Dietrich W. Beelen, MD, PhD, Ahmet H. Elmaagacli

Blood (2013) 122 (21): 3287.

https://doi.org/10.1182/blood.V122.21.3287.3287

Published: 2013

Journal Articles

Reduced Relapse Risk In Patients With AML After Hhcmv-Replication Post Transplantation-First Results Of a Prospective Registration Trial

Ahmet H. Elmaagacli, MD, Nina-Kristin Steckel, MD, Meltem Kekec, Rudolf Trenschel, Markus Ditschkowski, MD, Tanja Gromke, Sandra Christoph, Hellmut Ottinger, MD, Dietrich Beelen, Michael Koldehoff, MD

Blood (2013) 122 (21): 5503.

https://doi.org/10.1182/blood.V122.21.5503.5503

Published: 2013

Journal Articles

Human Chorionic Gonadotropin Hormone Induces Indoleamine 2,3-Dioxygenase and Interleukin-10 Expression In Patients With Graft-Versus-Host-Disease

Ahmet H. Elmaagacli, MD, Markus Ditschkowski, MD, Nina-Kristin Steckel, MD, Hellmut Ottinger, MD, Uwe Hillen, MD, Rudolf Trenschel, Dietrich Beelen, MD, Michael Koldehoff, MD

Blood (2013) 122 (21): 911.

https://doi.org/10.1182/blood.V122.21.911.911

Published: 2013

Journal Articles

Influence of Ceacams Expression in Graft-Versus-Host Disease After Allogeneic Transplantation

Michael Koldehoff, MD, Janine D. Dreesen, Ahmet H. Elmaagacli, MD, Dietrich W. Beelen, MD, Bernhard B. Singer, PhD

Blood (2012) 120 (21): 4490.

https://doi.org/10.1182/blood.V120.21.4490.4490

Published: 2012

Journal Articles

CMV-Replication After Allogeneic Stem Cell Transplantation Is Associated with a Gvhd-Independent Reduced Relapse Risk in Lymphoma

Ahmet H Elmaagacli, MD, PhD, Michael Koldehoff, MD, Nina K. Steckel, MD, Yael Hegerfeldt, MD, Markus Ditschkowski, Sandra Christoph, MD, Tanja Gromke, Rudof Stefan Ross, Hellmut Ottinger, Dietrich Beelen

Blood (2012) 120 (21): 1635.

https://doi.org/10.1182/blood.V120.21.1635.1635

Published: 2012

Journal Articles

Different Panel of Gene Variants Influence Outcome of Transplant From Sibling Donors Compared to HLA-Identical Unrelated Donors

Ahmet H Elmaagacli, MD, PhD, Michael Koldehoff, MD, Nina Kristin Steckel, Markus Ditschkowski, Rudolf Trenschel, MD, Hellmut Ottinger, Dietrich W. Beelen, MD

Blood (2012) 120 (21): 4182.

https://doi.org/10.1182/blood.V120.21.4182.4182

Published: 2012

Journal Articles

Influence of Micrornas Expression in Graft-Versus-Host Disease After Allogeneic Transplantation.

Michael Koldehoff, MD, Christina Maniera, Nina Steckel, MD, Ahmet H. Elmaagacli, MD, Dietrich W. Beelen, MD

Blood (2012) 120 (21): 3062.

https://doi.org/10.1182/blood.V120.21.3062.3062

Published: 2012

Journal Articles

Response: T cells are required for the CMV-induced antileukemia effect after transplant

Ahmet H. Elmaagacli, Michael Koldehoff, Monika Lindemann, Marlene Sonius, Markus Ditschkowski, Nina Steckel, Dietrich W. Beelen

Blood (2012) 119 (4): 1090–1091.

https://doi.org/10.1182/blood-2011-11-386821

Published: 2012

Journal Articles

Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk: evidence for a putative virus-versus-leukemia effect in acute myeloid leukemia patients

Ahmet H. Elmaagacli, Nina K. Steckel, Michael Koldehoff, Yael Hegerfeldt, Rudolf Trenschel, Markus Ditschkowski, Sandra Christoph, Tanja Gromke, Lambros Kordelas, Hellmut D. Ottinger, Rudolf S. Ross, Peter A. Horn, Susanne Schnittger, Dietrich W. Beelen

Blood (2011) 118 (5): 1402–1412.

https://doi.org/10.1182/blood-2010-08-304121

Published: 2011

Journal Articles

A Cytomegalovirus Reactivation Is Associated with An Improved Progression-Free Survival Rate In Patients with Lymphoma After Allogeneic Transplant

Ahmet H Elmaagacli, Sandra Christoph, Michael Koldehoff, MD, Nina Steckel, Rudolf Trenschel, Hellmut Ottinger, Dietrich Beelen

Blood (2010) 116 (21): 4912.

https://doi.org/10.1182/blood.V116.21.4912.4912

Published: 2010

Journal Articles

Incidence and Outcome of Auto/Alloimmune Hepatitis with Hepatic Graft-Versus-Host Disease After Hematopoietic Stem Cell Transplantation.

Michael Koldehoff, MD, Ahmet H Elmaagacli, Reinhild Klein, Dietrich Beelen

Blood (2010) 116 (21): 4534.

https://doi.org/10.1182/blood.V116.21.4534.4534

Published: 2010

Journal Articles

No influence of gene polymorphism of LCT (C13910T) on transplantation outcomes in acute myeloid leukemia patients who received transplantations from HLA-identical sibling donors

Ahmet H. Elmaagacli, Nina Steckel, Markus Ditschkowski, Yael Hegerfeldt, Hellmut Ottinger, Rudolf Trenschel, Dietrich W. Beelen

Blood (2010) 115 (17): 3644–3645.

https://doi.org/10.1182/blood-2010-02-267443

Published: 2010

NARROW

Interrelation of 5q-Deletions and Mutations of TP53 in Patients with Myelodysplastic Syndromes and Complex Aberrations

Mutation Profile of PPM1D and TP53 in Patients with Myelodysplastic Syndromes and Complex Chromosome Abnormalities

Long-Term Survival after Transplantation in Patients with Chronic Myeloid Leukemia from HLA-Compatible Unrelated Donors: May the Stem Cell Source Influence the Outcome?

Cytomegalovirus replication reduces the relapse incidence in patients with acute myeloid leukemia

Higher Incidence of Secondary AML and Adverse Molecular Markers, Together with Lower CR and Higher AML Related Death Rates in Elderly Compared to Younger Patients: Results from 2435 Patients Included in the Two German AML Intergroup Studies

Role Of miRNA Expression As Novel Biomarker Of GvHD After Allogeneic Stem Cell Transplantation

Mer Receptor Tyrosine Kinase Is a Novel Therapeutic Target In Multiple Myeloma

Comparison Of Different Pretransplant Predictive Scores In Patients With Refractory Acute Myeloid Leukemia After Allogeneic Stem Cell Transplantation Including Highdose Melphalan: Results Of a Double-Center Observational Study

Non Interventional Prospective Study On The Effect Of 48 Gene Variants On Different Endpoints After Allogeneic Stem Cell Transplantation For Patients With Acute Myeloid Leukemia

Reduced Relapse Risk In Patients With AML After Hhcmv-Replication Post Transplantation-First Results Of a Prospective Registration Trial

Human Chorionic Gonadotropin Hormone Induces Indoleamine 2,3-Dioxygenase and Interleukin-10 Expression In Patients With Graft-Versus-Host-Disease

Influence of Ceacams Expression in Graft-Versus-Host Disease After Allogeneic Transplantation

CMV-Replication After Allogeneic Stem Cell Transplantation Is Associated with a Gvhd-Independent Reduced Relapse Risk in Lymphoma

Different Panel of Gene Variants Influence Outcome of Transplant From Sibling Donors Compared to HLA-Identical Unrelated Donors

Influence of Micrornas Expression in Graft-Versus-Host Disease After Allogeneic Transplantation.

Response: T cells are required for the CMV-induced antileukemia effect after transplant

Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk: evidence for a putative virus-versus-leukemia effect in acute myeloid leukemia patients

A Cytomegalovirus Reactivation Is Associated with An Improved Progression-Free Survival Rate In Patients with Lymphoma After Allogeneic Transplant

Incidence and Outcome of Auto/Alloimmune Hepatitis with Hepatic Graft-Versus-Host Disease After Hematopoietic Stem Cell Transplantation.

No influence of gene polymorphism of LCT (C13910T) on transplantation outcomes in acute myeloid leukemia patients who received transplantations from HLA-identical sibling donors

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only